Anti-CLauDiN 18 antibodies and methods of use thereof
US11407828B2 · kind B2 · utility
0Cited by
28References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2020 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Feb 3, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies that specifically bind to the human tight junction molecule CLDN18.2 and have functional properties that make them suitable for use in antibody-based immunotherapies of a disease associated with aberrant expression of CLDN18.2 are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.